Evaluation
- Upon referral, the patient
meets with Dr. Maharaj, who reviews the patient's medical
history and consults with the referring oncologist. A
clinical team then evaluates the information to assess whether
the patient has met the criteria and is eligible for a
transplant.
Administration and Education
- The
administrative staff at the South Florida Bone Marrow Stem Cell
Transplant Institute facilitates insurance arrangements for the
patient and provides assistance with lodging if necessary.
The patient receives a complete orientation of the transplant
process, and is given educational materials and information
regarding patient support services.
Induction
- The patient receives
conventional doses of chemotherapy under the supervision of a
referring oncologist. Transplant eligibility is further
evaluated based on the cancer tissue's sensitivity to
chemotherapy.
Mobilization
- The patient receives
chemotherapy at five times the conventional dosage for three to
five days. Stimulating drugs for stem cell growth are
given to the patient simultaneously via a catheter.
Harvest and Storage
- Once the stem cell
count in the peripheral blood reaches acceptable levels, daily
harvesting sessions begin collecting the needed number of stem
cells for transplant. Collected cells are processed, cryo-preserved (frozen), and stored until time of transplant.
High Dosage Chemotherapy
- When the
patient recovers from mobilization chemotherapy, he or she
receives high-dose chemotherapy at ten times the conventional
dosage for five to seven consecutive days. During this
process, the patient becomes severely immuno-compromised, and is
monitored by the transplant team 24 hours a day at the Institute
and by the home-care nursing team.
Transplant
- The reinfusion of stem
cells takes place 48 hours following high-dose
chemotherapy. Stem cells are reintroduced into the
bloodstream through a central line. Once reintroduced,
they begin to produce new blood cells.
Recovery
- This period generally lasts
two weeks. The patients blood count returns to normal
levels and the immune system recovers.
Follow-up
- Patients return for weekly
follow-up visits for the first month post-transplant, and then
at the third and sixth months. After that, annual visits
are scheduled.
Bone marrow is
the soft, sponge-like material found in the bones. Its
main function is to produce primitive or immature cells called
stem cells (also called "progenitor cells").
These cells have the ability to divide into more stem cells or
into white blood cells (WBCs), red blood cells (RBCs), and
platelets, depending upon the body's needs at that moment.
White blood cells
(also called "leukocytes") help the body defend itself
against infection and other disease, by destroying
"foreign" substances such as bacteria or viruses.
When infection is present, the body increases the production of
the WBC. When the number of WBC in the blood is low, the
body has a more difficult time warding off infection.
Red blood cells
(also called "erythrocytes") carry oxygen, with the
aid of a protein called hemoglobin, from the lungs to cells in
all parts of the body. Oxygen helps process the nutrients
from the food that we eat. RBCs also carry back carbon dioxide
(considered "waste material") from the cells to the
lungs. When the number of RBC in the blood is low, a
condition called anemia results.
Platelets help
the blood to clot and thus, preventing bleeding. Low
number of platelets in the blood (a condition called
thrombocytopenia) may cause easy bruising and bleeding.
In adults, stem
cells can be found mostly in marrows of the bones of the skull,
back, chest, hips and upper arms and legs. In children,
they can be found throughout most of the marrows. Stem
cells, however, can also be found circulating in the blood
throughout the body and are called peripheral blood stem cells.
Q: How are
bone marrow and stem cells obtained for the transplant?
Bone marrow and
stem cells can be obtained or "harvested" from the
patient (autologous) or from another individual (allogeneic),
but are always collected before very high doses of anti-cancer
drugs (chemotherapy) and/or high energy rays (radiotherapy) are
administered.
Bone marrow is
usually taken from the hip bones (pelvis) using a large needle
or a special syringe inserted several times into the pelvic bone
through small incisions to draw out the marrow. The
"harvested" marrow is then processed to remove blood
and bone fragments. This process of obtaining stem cells is also
called aspiration, which may require local or general
anesthesia, and is usually done in the operating room. It
may require the patient to stay in the hospital for 1-2 nights,
but some hospitals can perform a bone marrow harvest as an
outpatient. The site of the needle puncture will be tender
for about a week with slight scars forming. The patient
or donor may feel some mild stiffness and soreness but can be
lessened through exercise and pain medication.
A newer method of
collecting or harvesting stem cells is called apheresis or
leukapheresis. Blood is obtained through a line (central
venous catheter) inserted into a large vein and passed through a
machine that removes stem cells. The rest of the blood is
returned to the patient. The process may take 2 to 4
hours, and usually does not require staying in the hospital
overnight. There are fewer stem cells circulating in the
blood when compared to those found in the marrow.
Transplant physicians are therefore looking into ways to
increase the number of stem cells that can be harvested. By
giving the patient "growth factors" (substances that
are naturally produced by the body but can also be made in
laboratories), the transplant physicians help stimulate the body
to make more stem cells. Since only a small amount of
marrow or stem cells are removed, the procedure seldom poses
significant problems or results in bad side effects.
Q:
How
are stem cells used for the transplant?
Once the stem
cells are obtained, the marrow or stem cells are either
preserved and frozen until needed (in an autologous transplant)
or are given to the recipient almost immediately (in an
allogeneic transplant).
The patient is
then given very high doses of anti-cancer drugs and/or radiation
(called "conditioning") to get rid of the cancer cells
throughout the body; to make space for the new marrow and; in an
allogeneic transplant, to reduce the risk of the patient
rejecting the cells or marrow taken from another person.
The bone marrow or stem cells that were previously collected are
given to the patient through a central venous catheter to help
re-grow normal blood cells and reduce the chance of severe
infection, bleeding, or anemia.
Q: Is there
any evidence of success for stem cell/bone marrow transplant?
As improvements
are being made in the way the procedure is done, stem cell/bone
marrow transplantation is becoming more commonly accepted and
effectively used in treating many cancers and leukemias.
Researchers are finding better results in the use of stem
cell/bone marrow transplant in patients with breast cancer,
Hodgkin's disease, non-Hodgkin's lymphoma, leukemia, multiple
myeloma, neuroblastoma and testicular cancer.
In addition, the
BMSCTI transplant team is investigating the use of stem
cell/bone marrow transplant in many other cancers including
sarcomas, brain tumors and ovarian cancer. The transplant
team is also looking at the role of hematopoietic growth factors
(also called "colony-stimulating factors" or CSFs),
which are proteins that help the stem cells develop into blood
cells, (a) in increasing the number of stem cells that can be
harvested during apheresis, (b) in helping the stem cells
develop into mature blood cells quickly, thus preventing
life-threatening infections, anemia or bleeding, (c) in
stimulating the growth of platelets in order to complement or
replace platelet transfusion, thus cutting down the number and
the costs of required transfusions, and (d) in stimulating the
growth of red blood cells (RBCs), thus reducing the need for and
the costs of RBC transfusions.
Criteria
for Hospital Admission:
Hypotension
Bleeding
Infection
Cardiac
Failure; Cardiac Arrhythmia
Respiratory
Distress
Severe
Renal Insufficiency
Neurological
Dysfunction
Intractable
Nausea, Vomiting, Diarrhea, and Fluid
Depletion
Psychiatric
Emergency
Severe
mucositis not contrtolled with analgesics
which can be given at home.
Any
other complication that cannot be treated in
the outpatient setting or manageable in the
home environment.
Above: Dr. Maharaj discussing a patient case with the
pharmacist at the institute.
History of Bone Marrow Transplants
Bone marrow/stem cell transplant procedures have
been around since the 1970's, but were not widely accepted in the United
States until the mid to late '80's. Today, BM/SCTs are utilized to treat
a variety of blood disorders and cancers including acute and chronic myeloid
leukemia, multiple myeloma, Hodgkin's disease, non-Hodgkin's lymphoma, germ
cell tumor, breast cancer, and ovarian cancer.
The beneficial effects of
BM/SCTs have been well documented
through outcomes studies. For each disorder, the disease-free survival rates
for transplant patients are significant when compared to patients receiving
conventional chemotherapy.
What Lies Ahead?
The future of BM/SCT procedures are being investigated for
curative use in other areas, such as autoimmune diseases (e.g., rheumatoid
arthritis and lupus) and neurologic disorders (e.g.,multiple sclerosis).
The procedure appears promising for these disorders ironically because of its
immunoablative effects, as high-dose chemotherapy can diminish overactivity of
the immune system that characterizes certain autoimmune and neurologic
disorders. As the procedure is expanded to treat
diseases other than cancers, the number of people who can benefit from BM/SCT
will increase.
Bethesda Support Groups
Bethesda Memorial Hospital offers a variety of
support groups to help individuals, families, and friends understand and cope
with life experiences. All groups meet at Bethesda Memorial Hospital
unless otherwise noted.
Al-Anon
For families and friends affected by alcoholism. Each Friday
at 8:00pm. Call 278-7733 or 737-7733, ext.
4405. Offered in cooperation with Bethesda Memorial Hospital.
Anxiety Support Group
Meets every Tuesday from 6:30pm to 8:00pm. Call
737-7733, ext. 4405. Offered in cooperation with Bethesda Memorial Hospital.
Breast Cancer Support Group
Information, discussions and support for people with breast
cancer. Family and friends welcome. 3rd Tuesday of each month from
5:30-7:30pm. Call Leslie Pollart, RN, at 737-7733, ext. 4540.
Coping With Cancer
Support and educational programs for cancer patients and their
support persons. Each Tuesday at 4:30pm. Call 278-7733 or 737-7733, ext. 4181.
Nicotine Anonymous
Support and information for people who wish to stop smoking.
Each Friday at 7:00pm. Call 737-7733, ext.
4405. Offered in cooperation with Bethesda Memorial Hospital.
Parent to Parent Support Group
Designed to meet the needs of families with special needs
children. Meets at Bethesda Health City every other Tuesday from 10-11:00am,
Conference room "C". Call Pam or Randee at 842-3213.
Partners Against Cancer Support Group
Information and support are provided for all cancer patients
and their support persons. 1st Tuesday of each month at 5:30pm. Call Nancy
Johnson at 737-7733, ext. 4177.
Prostate Support Group
Support for prostate cancer patients, families and friends.
2nd Wednesday of each month at 5:30pm. Call 278-7733 or 737-7733, ext. 4181.
Stroke Club
Survivors of stroke, friends and family share
experiences and help each other cope with feelings. 1st Sunday of each month
at 1:00pm. Call Nancy Spence, 278-7733 or 737-7733, ext. 4960.
Trigeminal Neuralgia Assoc. Support Group
Meets May 21, September 10 and November 12 in the
Dolphin/Manatee rooms at 1:30pm. Call Lucy Childs at 733-6930 for information.
Offered in cooperation with Bethesda Memorial Hospital